Dr. Holly L. Thacker lists the top seven women's health concerns and how women can help prevent and treat the concerns.

Agile Therapeutics, Inc.

How do I know menopause is coming? Will I gain weight? Will I need to take hormones? And is there anything I can do about those annoying hot flashes? Women's health specialist Pelin Batur, MD, walks us through what to expect.

Dr. Oluwatosin Goje and Dr. Taryn Smith discuss the latest updates on the Coronavirus (COVID-19) and what to do to prevent and treat this virus.

Reuters

Rates of three common sexually transmitted infections — syphilis, gonorrhea and chlamydia — are at an all-time high in the U.S. What’s behind this rise, who’s most at risk and how can we protect ourselves? Oluwatosin Goje, MD, an Ob/Gyn who specializes in infectious diseases, explains.

Read Dr. Holly L. Thacker and Center for Specialized Women's Health Fellowship graduate Dr. Camille Moreno’s column on longevity and diets.

Forbes

Dr. Taryn Smith discusses what treatments are best for high and low levels of testosterone in women.

Read Dr. Holly L. Thacker’s annual wrap up column on the top women’s health advances in 2019 and an eye towards what could be coming in 2020!

Volunteer to bring this simple and fabulous sweet potato dish for your next holiday meal. Don’t save for only the holidays — eat all year round!

High physician/patient convenience and satisfaction cited

Read Dr. Holly L. Thacker's column on the latest contraception options for women.

Read senior Specialized Women’s Health fellow, Dr. Taryn Smith’s column on updates from the 2019 North American Menopause Society. Dr. Smith was honored as a new investigator award winner at the NAMS meeting for her quality improvement in osteoporosis research, as well as one of our graduated fellows, Dr. Heather Foreman Hirsh. Dr. Hirsh is now at Harvard and won the top research poster on menopause and metabolic parameters.

Read Speaking of Women’s Health Founder and Chief Creative Strategist, Dianne Dunkelman’s column on her inspiring story on fatty liver and the hidden links to cirrhosis of the liver, along with our Executive Director, Dr. Holly L. Thacker.

New Tymlos Patch StudyThe trial compares Abaloparatide/Tymlos(R) injection vs Tymlos(R) patch. The patch is applied for 10 minutes daily and avoids the need for daily subcutaneous injection.Every woman with osteoporosis who gets enrolled in this study will receive active treatment free of charge in that there is no placebo group. Patients are randomized to either daily injection or patch. The study is 12 months and requires about 14 visits to Cleveland Clinic's main campus. Parking, mileage,…

E-cigarettes and vaping are relatively new and many have thought of them as a helpful alternative to quit traditional smoking. But now, reports of serious respiratory illnesses likely tied to vaping are popping up across the country. Having identified nearly 1,500 lung illnesses and 33 deaths, The Centers for Disease Control and Prevention (CDC) is investigating multiple reports of serious respiratory illnesses likely tied to vaping. Learn more about the dangers of vaping from Cleveland Clinic pulmonologist and smoking cessation specialist, Dr. Humberto Choi.

A dual-acting osteoporosis drug. Minimally invasive mitral valve surgery. New treatment for peanut allergies. These are some of the innovations that will enhance healing and change healthcare in the coming year, according to a distinguished panel of doctors and researchers.Cleveland Clinic announced the Top 10 Medical Innovations for 2020 at a multimedia presentation that capped off the 2019 Medical Innovation Summit. Now in its 17th year, the annual Medical Innovation Summit is organized by…

Nothing beats this all-time easy, favorite barbeque chicken pizza.

A new drug to treat most cystic fibrosis patients has been approved by the U.S. Food and Drug Administration.Trikafta (elexacaftor/ivacaftor/tezacaftor) is the first triple combination therapy available to treat patients with the most common cystic fibrosis mutation. Its list price is $311,000 a year, same as one of the maker's earlier treatments for the genetic disease.Trikafta is approved for patients aged 12 and older who have at least one F508del mutation in the cystic fibrosis…